Table 3 Patient comorbidities characteristics
Charlson Comorbidity | Weight | N | % |
|---|---|---|---|
Diabetes without complications | 1 | 129 | 19.4 |
Chronic pulmonary disease | 1 | 94 | 14.1 |
Cerebrovascular disease | 1 | 58 | 8.7 |
Myocardial infarction | 1 | 57 | 8.6 |
Connective tissue disease | 1 | 53 | 8.0 |
Congestive heart failure | 1 | 30 | 4.5 |
Dementia | 1 | 22 | 3.3 |
Peripheral vascular disease | 1 | 18 | 2.7 |
Peptic ulcer disease | 1 | 15 | 2.3 |
Liver disease, mild | 1 | 2 | 0.30 |
Renal disease, moderate or severe | 2 | 60 | 9.0 |
Diabetes with end organ damage | 2 | 22 | 3.3 |
Malignant tumor (within five years) | 2 | 17 | 2.6 |
Leukemia, polycythemia | 2 | 4 | 0.60 |
Lymphoma, multiple myeloma | 2 | 3 | 0.45 |
Hemiplegia | 2 | 2 | 0.30 |
Liver disease, moderate or severe | 3 | 2 | 0.30 |
Metastatic solid malignancy | 6 | 0 | 0 |
Acquired immunodeficiency syndrome (AIDS) | 6 | 0 | 0 |